Edwards Lifesciences Corp — Director's Dealing 2012

Apr 27, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Edwards Lifesciences Corp (EW)
CIK: 0001099800
Period of Report: 2012-04-26

Reporting Person: Abate Thomas M (CVP, CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-04-26	Common Stock	M	10000.0000	$13.0050	Acquired	57902.0000	Direct
2012-04-26	Common Stock	S	541.0000	$82.1000	Disposed	57361.0000	Direct
2012-04-26	Common Stock	S	9459.0000	$81.4300	Disposed	47902.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-04-26	Employee Stock Option (Right to Acquire)	$13.0050	M	10000.0000	Disposed	2012-05-07	Common Stock (10000.0000)	Direct

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 29, 2011.

F2: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.

F3: This transaction was executed in multiple trades at prices ranging from $82.04 to $82.17. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F4: This transaction was executed in multiple trades at prices ranging from $80.95 to $81.93. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.